Targeting the DNA Damage Response in Glioma: Emerging New Concepts and Novel Directions

Time: 8:30 am


  • Overview of the DNA damage response (DDR) and how it can be targeted therapeutically for GBM
  • Review on promising new DDR inhibitors and DNA damaging agents, which are either in development or in the clinic for GBM
  • Discuss emerging DDR targets, key hurdles, and future directions in the GBM space